By Senators Billig, Frockt, Hargrove

ADOPTED 3/10/2015

On page 3, after line 14 of the amendment, insert the following:

NEW SECTION.  Sec. 4.  "A new section is added to chapter 69.41 RCW to read as follows:

For the purposes of the patient counseling requirement adopted in rule by the pharmacy quality assurance commission pursuant to RCW 18.64.005(7), a dispensing pharmacist who substitutes an interchangeable biological product for the biological product being prescribed must disclose this substitution to the patient or the patient's representative. This disclosure must include the name of the product and the manufacturer of the interchangeable biological product dispensed and must occur at the time the interchangeable biological product is dispensed."

Renumber the remaining sections consecutively and correct any internal references accordingly.

EFFECT: Requires the pharmacist to notify the patient if an interchangeable biological product is being substituted for the drug prescribed. Notification must occur at the time of dispensing.